JP2021506788A5 - - Google Patents
Info
- Publication number
- JP2021506788A5 JP2021506788A5 JP2020532583A JP2020532583A JP2021506788A5 JP 2021506788 A5 JP2021506788 A5 JP 2021506788A5 JP 2020532583 A JP2020532583 A JP 2020532583A JP 2020532583 A JP2020532583 A JP 2020532583A JP 2021506788 A5 JP2021506788 A5 JP 2021506788A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- compound according
- linker
- antibody
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024011679A JP2024050717A (ja) | 2017-12-13 | 2024-01-30 | 生物学的に活性な化合物を含むイオン性ポリマー |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762598365P | 2017-12-13 | 2017-12-13 | |
| US62/598,365 | 2017-12-13 | ||
| PCT/US2018/065432 WO2019118714A1 (en) | 2017-12-13 | 2018-12-13 | Ionic polymers comprising biologically active compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024011679A Division JP2024050717A (ja) | 2017-12-13 | 2024-01-30 | 生物学的に活性な化合物を含むイオン性ポリマー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021506788A JP2021506788A (ja) | 2021-02-22 |
| JP2021506788A5 true JP2021506788A5 (https=) | 2023-08-09 |
Family
ID=65023989
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532583A Pending JP2021506788A (ja) | 2017-12-13 | 2018-12-13 | 生物学的に活性な化合物を含むイオン性ポリマー |
| JP2024011679A Pending JP2024050717A (ja) | 2017-12-13 | 2024-01-30 | 生物学的に活性な化合物を含むイオン性ポリマー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024011679A Pending JP2024050717A (ja) | 2017-12-13 | 2024-01-30 | 生物学的に活性な化合物を含むイオン性ポリマー |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20210128591A1 (https=) |
| EP (1) | EP3724200A1 (https=) |
| JP (2) | JP2021506788A (https=) |
| KR (1) | KR102773157B1 (https=) |
| CN (1) | CN111465608A (https=) |
| WO (1) | WO2019118714A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| US11827661B2 (en) | 2015-02-26 | 2023-11-28 | Sony Group Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| CN109415574B (zh) | 2016-04-01 | 2021-05-28 | 索尼公司 | 具有刚性间隔基团的超亮二聚体或聚合物染料 |
| AU2017240154B2 (en) | 2016-04-01 | 2021-08-12 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes |
| WO2017177065A2 (en) | 2016-04-06 | 2017-10-12 | Sony Corporation | Ultra bright dimeric or polymeric dyes with spacing linker groups |
| EP3455299B1 (en) | 2016-05-10 | 2024-01-17 | Sony Group Corporation | Compositions comprising a polymeric dye and a cyclodextrin and uses thereof |
| JP7527537B2 (ja) | 2016-05-10 | 2024-08-05 | ソニーグループ株式会社 | ペプチド骨格を有する超明色ポリマー染料 |
| EP3455300A1 (en) | 2016-05-11 | 2019-03-20 | Sony Corporation | Ultra bright dimeric or polymeric dyes |
| EP3464477A1 (en) | 2016-06-06 | 2019-04-10 | Sony Corporation | Ionic polymers comprising fluorescent or colored reporter groups |
| JP7312929B2 (ja) | 2016-07-29 | 2023-07-24 | ソニーグループ株式会社 | 超明色二量体またはポリマー色素およびその調製のための方法 |
| WO2019071153A1 (en) | 2017-10-05 | 2019-04-11 | Sony Corporation | PROGRAMMABLE DENDRITIC MEDICINES |
| KR20260011205A (ko) | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| CN111836645A (zh) | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| US12539334B2 (en) | 2018-01-12 | 2026-02-03 | Sony Group Corporation | Phosphoalkyl polymers comprising biologically active agents |
| CN111565756A (zh) | 2018-01-12 | 2020-08-21 | 索尼公司 | 包含生物活性化合物的具有刚性间隔基团的聚合物 |
| EP3737417B1 (en) | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| KR102742386B1 (ko) | 2018-03-19 | 2024-12-16 | 소니그룹주식회사 | 형광 신호 향상을 위한 2가 금속의 사용 |
| CN118480073A (zh) | 2018-03-21 | 2024-08-13 | 索尼公司 | 具有连接体基团的聚合串联染料 |
| EP3775052B1 (en) | 2018-03-30 | 2024-06-05 | Becton, Dickinson and Company | Water-soluble polymeric dyes having pendant chromophores |
| JP7580689B2 (ja) | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| KR20210032434A (ko) | 2018-07-13 | 2021-03-24 | 소니 주식회사 | 유기인산염 단위를 포함하는 백본을 갖는 중합체성 염료 |
| WO2021062176A2 (en) | 2019-09-26 | 2021-04-01 | Sony Corporation | Polymeric tandem dyes with linker groups |
| EP4038081A1 (en) | 2019-09-30 | 2022-08-10 | Sony Group Corporation | Nucleotide probes |
| EP4256078A1 (en) | 2020-12-07 | 2023-10-11 | Sony Group Corporation | Spacing linker group design for brightness enhancement in dimeric or polymeric dyes |
| WO2022216450A1 (en) | 2021-04-07 | 2022-10-13 | Becton, Dickinson And Company | Water-soluble fluorescent polymeric dyes |
| KR20260023583A (ko) | 2023-08-31 | 2026-02-20 | 후지필름 가부시키가이샤 | 표적화 약물 복합체 및 이것을 포함하는 의약, 및, 화합물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19633268A1 (de) * | 1996-08-19 | 1998-02-26 | Hoechst Ag | Polymere Gallensäure-Resorptionsinhibitoren mit gleichzeitiger Gallensäure-Adsorberwirkung |
| US6852709B2 (en) * | 2000-05-31 | 2005-02-08 | Johns Hopkins University | Biologically useful polyphosphates |
| KR101564796B1 (ko) * | 2008-03-10 | 2015-10-30 | 고쿠리츠다이가쿠호우진 도쿄다이가쿠 | 비하전성 친수성 블록 및 측사슬의 일부에 소수성 기가 도입된 카티온성 폴리아미노산 블록을 포함하여 이루어지는 공중합체, 그 사용 |
| CA2745307A1 (en) * | 2008-12-12 | 2010-06-17 | University Of Massachusetts | Polyesters with grafted zwitterions |
| WO2012039855A1 (en) * | 2010-09-22 | 2012-03-29 | The Board Of Regents Of The University Of Texas System | Ph-sensitive compositions for delivery of beta lapachone and methods of use |
| US10709791B2 (en) * | 2014-11-12 | 2020-07-14 | University Of Washington | Stabilized polymeric carriers for therapeutic agent delivery |
| US11512160B2 (en) * | 2015-06-02 | 2022-11-29 | University Of Washington | Free-standing non-fouling polymers, their compositions, and related monomers |
| JP7527537B2 (ja) * | 2016-05-10 | 2024-08-05 | ソニーグループ株式会社 | ペプチド骨格を有する超明色ポリマー染料 |
| EP3464477A1 (en) * | 2016-06-06 | 2019-04-10 | Sony Corporation | Ionic polymers comprising fluorescent or colored reporter groups |
| WO2017214615A1 (en) * | 2016-06-10 | 2017-12-14 | President And Fellows Of Harvard College | Library-scale engineering of metabolic pathways |
| CN111836645A (zh) * | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
-
2018
- 2018-12-13 CN CN201880080473.3A patent/CN111465608A/zh active Pending
- 2018-12-13 JP JP2020532583A patent/JP2021506788A/ja active Pending
- 2018-12-13 US US16/771,185 patent/US20210128591A1/en not_active Abandoned
- 2018-12-13 EP EP18834100.2A patent/EP3724200A1/en not_active Ceased
- 2018-12-13 WO PCT/US2018/065432 patent/WO2019118714A1/en not_active Ceased
- 2018-12-13 KR KR1020207020104A patent/KR102773157B1/ko active Active
-
2024
- 2024-01-30 JP JP2024011679A patent/JP2024050717A/ja active Pending
-
2025
- 2025-01-17 US US19/030,635 patent/US20250161467A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021506788A5 (https=) | ||
| JP2021503450A5 (https=) | ||
| JP2021510696A5 (https=) | ||
| JP7190548B2 (ja) | Ｈｄａｃ阻害剤とｐｄ－ｌ１阻害剤との組み合わせ療法 | |
| CN101547705B (zh) | 用于治疗新生物的组合物和方法 | |
| KR102023496B1 (ko) | 신규 결합제-약물 콘주게이트 (adc) 및 그의 용도 | |
| DeVay et al. | Improved lysosomal trafficking can modulate the potency of antibody drug conjugates | |
| JP2023530128A (ja) | 細胞結合分子とカンプトテシン類縁体との共役体 | |
| JP2023527116A (ja) | がんを治療するためのｅｚｈ２阻害剤の使用 | |
| CN111836645A (zh) | 可编程的聚合药物 | |
| WO2017192470A1 (en) | Combination therapy of anti-il-10 antibody and compositions comprising lipid nanoparticles and tlr9 agonist cpg oligonucleotides | |
| JP2024026138A (ja) | プラチナベースの薬剤と抗組織因子抗体－薬物コンジュゲートの組み合わせを用いるがんの治療方法 | |
| CA2351357A1 (en) | Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors | |
| JP7102423B2 (ja) | リポソームの薬物送達ビヒクル | |
| US20220313608A1 (en) | Treatment of breast cancer | |
| CA3137361A1 (en) | Administration of pd-1 inhibitors for treating skin cancer | |
| Alam et al. | Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate) | |
| JP2025501978A5 (https=) | ||
| JP2022543022A (ja) | 抗体‐ポリマー複合体 | |
| TW202340142A (zh) | Ｇｃｌ抑制劑 | |
| JP2024522607A (ja) | 治療薬の標的化送達のための組成物及び方法 | |
| WO2014184726A2 (en) | Compounds and their use in therapy | |
| CN120359047A (zh) | 用于靶向递送治疗剂的组合物和方法 | |
| WO2026030966A1 (zh) | Pi4k抑制剂及其应用 | |
| KR20210106197A (ko) | EGFR과 Her2 발현 암세포를 타겟으로 하는 항체-약물 중합체 개발 |